dc.contributor.author |
Gilling, Peter |
en |
dc.contributor.author |
Wilson, Liam C |
en |
dc.contributor.author |
King, Colleen J |
en |
dc.contributor.author |
Westenberg, Andre M |
en |
dc.contributor.author |
Frampton, Christopher M |
en |
dc.contributor.author |
Fraundorfer, Mark R |
en |
dc.date.accessioned |
2018-10-23T03:08:42Z |
en |
dc.date.issued |
2012-02 |
en |
dc.identifier.issn |
1464-4096 |
en |
dc.identifier.uri |
http://hdl.handle.net/2292/43273 |
en |
dc.description.abstract |
OBJECTIVE: To assess the durability of holmium laser enucleation of prostate in comparison to transurethral resection of the prostate (TURP). PATIENTS AND METHODS: Patients were enrolled in the present study between June 1997 and December 2000 and followed per protocol. All patients were urodynamically obstructed with a prostate volume of between 40 and 200 mL. At long-term follow-up, variables assessed included Benign Prostatic Hyperplasia Impact Index (BPHII), International Continence Society Short Form Male questionnaire (ICSmale-SF) and the International Index of Erectile Function (IIEF). Adverse events, including the need for retreatment, were specifically assessed. RESULTS: Thirty-one (14 holmium laser enucleation of the prostate [HoLEP] and 17 TURP) of the initial 61 patients were available, with 12 deceased and 18 lost to follow-up. The mean (range) follow-up was 7.6 (5.9-10.0) years and the mean (±sd) age at follow-up was 79.8 (±6.2) years. The mean (±sd) values (HoLEP vs TURP) were as follows: maximum urinary flow rate (Q(max)), 22.09 ± 15.47 vs 17.83 ± 8.61 mL/s; American Urological Association (AUA) symptom score, 8.0 ± 5.2 vs 10.3 ± 7.42; quality of life (QOL) score 1.47 ± 1.31 vs 1.31 ± 0.85; BPHII, 1.53 ± 2.9 vs 0.58 ± 0.79; IIEF-EF (erectile function), 11.6 ± 7.46 vs 9.21 ± 7.17; ICSmale Voiding Score (VS), 4.2 ± 3.76 vs 3.0 ± 2.41; ICSmale Incontinence Score (IS), 3.07 ± 3.3 vs 1.17 ± 1.4. There were no significant differences in any variable between the two groups beyond the first year. Of the assessable patients, none required re-operation for recurrent BPH in the HoLEP arm and three (of 17) required re-operation in the TURP arm . CONCLUSION: The results of this randomized trial confirm that HoLEP is at least equivalent to TURP in the long term with fewer re-operations being necessary. |
en |
dc.format.medium |
Print-Electronic |
en |
dc.language |
eng |
en |
dc.relation.ispartofseries |
BJU international |
en |
dc.rights |
Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. |
en |
dc.rights.uri |
https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm |
en |
dc.subject |
Humans |
en |
dc.subject |
Prostatic Hyperplasia |
en |
dc.subject |
Treatment Outcome |
en |
dc.subject |
Transurethral Resection of Prostate |
en |
dc.subject |
Quality of Life |
en |
dc.subject |
Aged |
en |
dc.subject |
Patient Satisfaction |
en |
dc.subject |
Male |
en |
dc.subject |
Laser Therapy |
en |
dc.subject |
Lasers, Solid-State |
en |
dc.title |
Long-term results of a randomized trial comparing holmium laser enucleation of the prostate and transurethral resection of the prostate: results at 7 years. |
en |
dc.type |
Journal Article |
en |
dc.identifier.doi |
10.1111/j.1464-410x.2011.10359.x |
en |
pubs.issue |
3 |
en |
pubs.begin-page |
408 |
en |
pubs.volume |
109 |
en |
dc.rights.holder |
Copyright: The author |
en |
dc.identifier.pmid |
21883820 |
en |
pubs.end-page |
411 |
en |
pubs.publication-status |
Published |
en |
dc.rights.accessrights |
http://purl.org/eprint/accessRights/RestrictedAccess |
en |
pubs.subtype |
Comparative Study |
en |
pubs.subtype |
Randomized Controlled Trial |
en |
pubs.subtype |
Journal Article |
en |
pubs.elements-id |
314619 |
en |
dc.identifier.eissn |
1464-410X |
en |
pubs.record-created-at-source-date |
2012-01-16 |
en |
pubs.dimensions-id |
21883820 |
en |